Assignee
RECORDATI IRELAND LTD
IL·6 granted patents·15 pending applications·43 citations·filing 2002–2017
Top patents by PatentIndex Score
21 records- 0189US7476689B2Therapeutic compositions for intranasal administration which include KETOROLACRECORDATI IRELAND LTD·Filed 2004·Granted Jan 13, 2009·23 cites·22 claims
- 0284US6852737B2Crude and crystalline forms of lercanidipine hydrochlorideRECORDATI IRELAND LTD·Filed 2002·Granted Feb 8, 2005·20 cites·18 claims
- 0353US2005192323A1Novel crude and crystalline forms of lercanidipine hydrochlorideRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 0453US2005239847A1Novel crude and crystalline forms of lercanidipine hydrochlorideRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 0550US7820701B2Amorphous lercanidipine hydrochloride and uses thereofRECORDATI IRELAND LTD·Filed 2006·Granted Oct 26, 2010·0 cites·22 claims
- 0650US7683179B2Lercanidipine saltsRECORDATI IRELAND LTD·Filed 2005·Granted Mar 23, 2010·0 cites·34 claims
- 0749US2007270436A1Novel amino- and imino-alkylpiperazinesRECORDATI IRELAND LTD·Filed 2007·Application pending·0 cites
- 0849US2004204459A1Novel crude and crystalline forms of lercanidipine hydrochlorideRECORDATI IRELAND LTD·Filed 2004·Application pending·0 cites
- 0949US2005101640A1Lisinopril/lercanidipine combination therapyRECORDATI IRELAND LTD·Filed 2004·Application pending·0 cites
- 1048US2004198789A1Lercanidipine/ARB/diuretic therapeutic combinationsRECORDATI IRELAND LTD·Filed 2004·Application pending·0 cites
- 1148US2005165025A1Combination therapy with 5HT 1A and 5HT 1B-receptor antagonistsRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 1246US2007185129A1Acid addition salts of thienopyrancarboxamide derivativesRECORDATI IRELAND LTD·Filed 2007·Application pending·0 cites
- 1345US2005260253A1Transmucosal gel formulationsRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 1445US2007066580A1Novel aldosterone antagonists and uses thereofRECORDATI IRELAND LTD·Filed 2006·Application pending·0 cites
- 1543US9889121B2Heterocyclylalkyne derivatives and their use as modulators of mGluR5 receptorsRECORDATI IRELAND LTD·Filed 2017·Granted Feb 13, 2018·0 cites·2 claims
- 1643US2008153888A1Alpha-2-delta ligand/nsaid therapeutic treatment of lower urinary tract disordersRECORDATI IRELAND LTD·Filed 2007·Application pending·0 cites
- 1741US2006199849A1Solid lercanidipine free baseRECORDATI IRELAND LTD·Filed 2006·Application pending·0 cites
- 1840US9593127B2Heterocyclylalkyne derivatives and their use as modulators of mGluR5 receptorsRECORDATI IRELAND LTD·Filed 2015·Granted Mar 14, 2017·0 cites·14 claims
- 1937US2006073200A1Lercanidipine capsulesRECORDATI IRELAND LTD·Filed 2005·Application pending·0 cites
- 2035US2003069285A1Novel solvate and crystalline forms of lercanidipine hydrochlorideRECORDATI IRELAND LTD·Filed 2002·Application pending·0 cites
- 2134US2010317630A1Novel heterocyclic compounds as mglu5 antagonistsRECORDATI IRELAND LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RECORDATI IRELAND LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →